PARNAX LAB
Back to Income Statement
|
PARNAX LAB Last 5 Year Revenue History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Net Sales | ₹249 Cr | ₹188 Cr | ₹189 Cr | ₹168 Cr | ₹163 Cr |
What is the latest Revenue of PARNAX LAB ?
| Year | Revenue |
|---|---|
| Mar2026 | ₹249 Cr |
| Mar2025 | ₹188 Cr |
| Mar2024 | ₹189 Cr |
| Mar2023 | ₹168 Cr |
| Mar2022 | ₹163 Cr |
How is Revenue of PARNAX LAB Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2026 | ₹249 Cr | 32.39 | |
| Mar2025 | ₹188 Cr | -0.52 | |
| Mar2024 | ₹189 Cr | 12.59 | |
| Mar2023 | ₹168 Cr | 2.81 | |
| Mar2022 | ₹163 Cr | - | |
Compare Revenue of peers of PARNAX LAB
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| PARNAX LAB | ₹126.8 Cr | 7% | -5.8% | -17.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹454,914.0 Cr | 3.9% | 7.8% | 13% | Stock Analytics | |
| DIVIS LABORATORIES | ₹300,380.0 Cr | 11.5% | 20.6% | 68% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹181,169.0 Cr | 1% | 1.8% | 34.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹114,933.0 Cr | 1.1% | 11.8% | 14.9% | Stock Analytics | |
| CIPLA | ₹114,478.0 Cr | 1.1% | 7.9% | -6.3% | Stock Analytics | |
PARNAX LAB Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| PARNAX LAB | 7% |
-5.8% |
-17.5% |
| SENSEX | 5.9% |
13% |
-1.9% |
You may also like the below Video Courses